Latham & Watkins Represents Kennedy Lewis Investment Management in Debt and Equity Financing for Impulse Dynamics

Funding to support commercial acceleration of the Optimizer Smart Mini, enrollment in a landmark clinical trial, and continued development of breakthrough technologies.

May 13, 2022

Impulse Dynamics, a global medical device company a medical device company organized in Curacao and headquartered in New Jersey focusing on heart failure conditions, has announced the completion of a US$101 million financing round comprised of both equity and debt. Participants include new investors, Alger and Squarepoint Capital LLC; existing investors, Abiomed, Inc. and Kennedy Lewis Investment Management LLC; and private investors from the company’s Board of Directors, including the company’s CEO, Simos Kedikoglou, MD.

Latham & Watkins LLP represented Kennedy Lewis Investment Management LLC in the financing with a deal team led by Bay Area finance partners Haim Zaltzman and Dan Van Fleet, with Houston associates Benjamin Gelfand and Hunter Newell. Advice was also provided on corporate matters by Bay Area partner Jim Morrone; on tax matters by Los Angeles partner Eric Cho and associate Kathryn Harrington; and on German law matters by Frankfurt corporate partner Torsten Volkholz and Hamburg finance associate Anna-Maria Kuckerz.

Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.